Santanu brings over 20 years of healthcare and consulting experience to Trinity Life Sciences. He has broad experience working with a range of global biotechnology, pharmaceutical and medical technology companies supporting commercial and price & access engagements across the HLS value chain including asset evaluation, GTM and market expansion, launch strategy planning, LCM and LOE strategy.

Before joining Trinity, Santanu was a Partner at Oliver Wyman Health & Life Science Practice (London) and Managing Director at Huron Healthcare Consulting. Prior to that, he was VP PMA at GfK Healthcare. Santanu co-founded a boutique healthcare consulting firm – J&D Associates (10 years) with offices in London and Boston. He began his career working in primary and hospital-based sales and marketing roles at Wyeth Laboratories (Women’s Health) and SKB (Vaccines).

His academic achievements include an MBA from Imperial College Business School and a BSc in Biochemistry from the University of London (Queen Mary’s College).

Santanu Das will be speaking at Winning in Europe: Optimizing Future Launch Strategies on Tuesday, April 30, 2024. His presentation is titled Are There Secrets to Navigating Access in the Evolving Payer Landscape?